2020-2025 Global Oligonucleotide Therapeutics Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

July 2021 | 114 pages | ID: 24F40A8E25F1EN
Maia Research

Abstracts

This report elaborates the market size, market characteristics, and market growth of the Oligonucleotide Therapeutics industry, and breaks down according to the type, application, and consumption area of Oligonucleotide Therapeutics. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Oligonucleotide Therapeutics in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Oligonucleotide Therapeutics market covered in Chapter 13:
Gilead
Santaris Pharma
Ionis Pharmaceuticals
Regulus Therapeutics
Pfizer
ContraVir
PCI Biotech
Biogen
Alnylam
Merck
SomaGenics

In Chapter 6, on the basis of types, the Oligonucleotide Therapeutics market from 2015 to 2025 is primarily split into:
Antisense
Ribozymes
Aptamers
miRNA
CpG/Immunostimulatory
RNAi
Others

In Chapter 7, on the basis of applications, the Oligonucleotide Therapeutics market from 2015 to 2025 covers:
Infectious Diseases
Oncology
Neurodegenerative Disorders
Cardiovascular Diseases
Kidney Diseases
Others

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025

Contents

1 OLIGONUCLEOTIDE THERAPEUTICS MARKET - RESEARCH SCOPE

1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 OLIGONUCLEOTIDE THERAPEUTICS MARKET - RESEARCH METHODOLOGY

2.1 Methodology
2.2 Research Data Source
  2.2.1 Secondary Data
  2.2.2 Primary Data
  2.2.3 Market Size Estimation
  2.2.4 Legal Disclaimer

3 OLIGONUCLEOTIDE THERAPEUTICS MARKET FORCES

3.1 Global Oligonucleotide Therapeutics Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
  3.2.1 Political Factors
  3.2.2 Economic Factors
  3.2.3 Social Factors
  3.2.4 Technological Factors
  3.2.5 Environmental Factors
  3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
  3.4.1 Risk Assessment on COVID-19
  3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
  3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 OLIGONUCLEOTIDE THERAPEUTICS MARKET - BY GEOGRAPHY

4.1 Global Oligonucleotide Therapeutics Market Value and Market Share by Regions
  4.1.1 Global Oligonucleotide Therapeutics Value ($) by Region (2015-2020)
  4.1.2 Global Oligonucleotide Therapeutics Value Market Share by Regions (2015-2020)
4.2 Global Oligonucleotide Therapeutics Market Production and Market Share by Major Countries
  4.2.1 Global Oligonucleotide Therapeutics Production by Major Countries (2015-2020)
  4.2.2 Global Oligonucleotide Therapeutics Production Market Share by Major Countries (2015-2020)
4.3 Global Oligonucleotide Therapeutics Market Consumption and Market Share by Regions
  4.3.1 Global Oligonucleotide Therapeutics Consumption by Regions (2015-2020)
  4.3.2 Global Oligonucleotide Therapeutics Consumption Market Share by Regions (2015-2020)

5 OLIGONUCLEOTIDE THERAPEUTICS MARKET - BY TRADE STATISTICS

5.1 Global Oligonucleotide Therapeutics Export and Import
5.2 United States Oligonucleotide Therapeutics Export and Import (2015-2020)
5.3 Europe Oligonucleotide Therapeutics Export and Import (2015-2020)
5.4 China Oligonucleotide Therapeutics Export and Import (2015-2020)
5.5 Japan Oligonucleotide Therapeutics Export and Import (2015-2020)
5.6 India Oligonucleotide Therapeutics Export and Import (2015-2020)
5.7 ...

6 OLIGONUCLEOTIDE THERAPEUTICS MARKET - BY TYPE

6.1 Global Oligonucleotide Therapeutics Production and Market Share by Types (2015-2020)
  6.1.1 Global Oligonucleotide Therapeutics Production by Types (2015-2020)
  6.1.2 Global Oligonucleotide Therapeutics Production Market Share by Types (2015-2020)
6.2 Global Oligonucleotide Therapeutics Value and Market Share by Types (2015-2020)
  6.2.1 Global Oligonucleotide Therapeutics Value by Types (2015-2020)
  6.2.2 Global Oligonucleotide Therapeutics Value Market Share by Types (2015-2020)
6.3 Global Oligonucleotide Therapeutics Production, Price and Growth Rate of Antisense (2015-2020)
6.4 Global Oligonucleotide Therapeutics Production, Price and Growth Rate of Ribozymes (2015-2020)
6.5 Global Oligonucleotide Therapeutics Production, Price and Growth Rate of Aptamers (2015-2020)
6.6 Global Oligonucleotide Therapeutics Production, Price and Growth Rate of miRNA (2015-2020)
6.7 Global Oligonucleotide Therapeutics Production, Price and Growth Rate of CpG/Immunostimulatory (2015-2020)
6.8 Global Oligonucleotide Therapeutics Production, Price and Growth Rate of RNAi (2015-2020)
6.9 Global Oligonucleotide Therapeutics Production, Price and Growth Rate of Others (2015-2020)

7 OLIGONUCLEOTIDE THERAPEUTICS MARKET - BY APPLICATION

7.1 Global Oligonucleotide Therapeutics Consumption and Market Share by Applications (2015-2020)
  7.1.1 Global Oligonucleotide Therapeutics Consumption by Applications (2015-2020)
  7.1.2 Global Oligonucleotide Therapeutics Consumption Market Share by Applications (2015-2020)
7.2 Global Oligonucleotide Therapeutics Consumption and Growth Rate of Infectious Diseases (2015-2020)
7.3 Global Oligonucleotide Therapeutics Consumption and Growth Rate of Oncology (2015-2020)
7.4 Global Oligonucleotide Therapeutics Consumption and Growth Rate of Neurodegenerative Disorders (2015-2020)
7.5 Global Oligonucleotide Therapeutics Consumption and Growth Rate of Cardiovascular Diseases (2015-2020)
7.6 Global Oligonucleotide Therapeutics Consumption and Growth Rate of Kidney Diseases (2015-2020)
7.7 Global Oligonucleotide Therapeutics Consumption and Growth Rate of Others (2015-2020)

8 NORTH AMERICA OLIGONUCLEOTIDE THERAPEUTICS MARKET

8.1 North America Oligonucleotide Therapeutics Market Size
8.2 United States Oligonucleotide Therapeutics Market Size
8.3 Canada Oligonucleotide Therapeutics Market Size
8.4 Mexico Oligonucleotide Therapeutics Market Size
8.5 The Influence of COVID-19 on North America Market

9 EUROPE OLIGONUCLEOTIDE THERAPEUTICS MARKET ANALYSIS

9.1 Europe Oligonucleotide Therapeutics Market Size
9.2 Germany Oligonucleotide Therapeutics Market Size
9.3 United Kingdom Oligonucleotide Therapeutics Market Size
9.4 France Oligonucleotide Therapeutics Market Size
9.5 Italy Oligonucleotide Therapeutics Market Size
9.6 Spain Oligonucleotide Therapeutics Market Size
9.7 The Influence of COVID-19 on Europe Market

10 ASIA-PACIFIC OLIGONUCLEOTIDE THERAPEUTICS MARKET ANALYSIS

10.1 Asia-Pacific Oligonucleotide Therapeutics Market Size
10.2 China Oligonucleotide Therapeutics Market Size
10.3 Japan Oligonucleotide Therapeutics Market Size
10.4 South Korea Oligonucleotide Therapeutics Market Size
10.5 Southeast Asia Oligonucleotide Therapeutics Market Size
10.6 India Oligonucleotide Therapeutics Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 MIDDLE EAST AND AFRICA OLIGONUCLEOTIDE THERAPEUTICS MARKET ANALYSIS

11.1 Middle East and Africa Oligonucleotide Therapeutics Market Size
11.2 Saudi Arabia Oligonucleotide Therapeutics Market Size
11.3 UAE Oligonucleotide Therapeutics Market Size
11.4 South Africa Oligonucleotide Therapeutics Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 SOUTH AMERICA OLIGONUCLEOTIDE THERAPEUTICS MARKET ANALYSIS

12.1 South America Oligonucleotide Therapeutics Market Size
12.2 Brazil Oligonucleotide Therapeutics Market Size
12.3 The Influence of COVID-19 on South America Market

13 COMPANY PROFILES

13.1 Gilead
  13.1.1 Gilead Basic Information
  13.1.2 Gilead Product Profiles, Application and Specification
  13.1.3 Gilead Oligonucleotide Therapeutics Market Performance (2015-2020)
13.2 Santaris Pharma
  13.2.1 Santaris Pharma Basic Information
  13.2.2 Santaris Pharma Product Profiles, Application and Specification
  13.2.3 Santaris Pharma Oligonucleotide Therapeutics Market Performance (2015-2020)
13.3 Ionis Pharmaceuticals
  13.3.1 Ionis Pharmaceuticals Basic Information
  13.3.2 Ionis Pharmaceuticals Product Profiles, Application and Specification
  13.3.3 Ionis Pharmaceuticals Oligonucleotide Therapeutics Market Performance (2015-2020)
13.4 Regulus Therapeutics
  13.4.1 Regulus Therapeutics Basic Information
  13.4.2 Regulus Therapeutics Product Profiles, Application and Specification
  13.4.3 Regulus Therapeutics Oligonucleotide Therapeutics Market Performance (2015-2020)
13.5 Pfizer
  13.5.1 Pfizer Basic Information
  13.5.2 Pfizer Product Profiles, Application and Specification
  13.5.3 Pfizer Oligonucleotide Therapeutics Market Performance (2015-2020)
13.6 ContraVir
  13.6.1 ContraVir Basic Information
  13.6.2 ContraVir Product Profiles, Application and Specification
  13.6.3 ContraVir Oligonucleotide Therapeutics Market Performance (2015-2020)
13.7 PCI Biotech
  13.7.1 PCI Biotech Basic Information
  13.7.2 PCI Biotech Product Profiles, Application and Specification
  13.7.3 PCI Biotech Oligonucleotide Therapeutics Market Performance (2015-2020)
13.8 Biogen
  13.8.1 Biogen Basic Information
  13.8.2 Biogen Product Profiles, Application and Specification
  13.8.3 Biogen Oligonucleotide Therapeutics Market Performance (2015-2020)
13.9 Alnylam
  13.9.1 Alnylam Basic Information
  13.9.2 Alnylam Product Profiles, Application and Specification
  13.9.3 Alnylam Oligonucleotide Therapeutics Market Performance (2015-2020)
13.10 Merck
  13.10.1 Merck Basic Information
  13.10.2 Merck Product Profiles, Application and Specification
  13.10.3 Merck Oligonucleotide Therapeutics Market Performance (2015-2020)
13.11 SomaGenics
  13.11.1 SomaGenics Basic Information
  13.11.2 SomaGenics Product Profiles, Application and Specification
  13.11.3 SomaGenics Oligonucleotide Therapeutics Market Performance (2015-2020)

14 MARKET FORECAST - BY REGIONS

14.1 North America Oligonucleotide Therapeutics Market Forecast (2020-2025)
14.2 Europe Oligonucleotide Therapeutics Market Forecast (2020-2025)
14.3 Asia-Pacific Oligonucleotide Therapeutics Market Forecast (2020-2025)
14.4 Middle East and Africa Oligonucleotide Therapeutics Market Forecast (2020-2025)
14.5 South America Oligonucleotide Therapeutics Market Forecast (2020-2025)

15 MARKET FORECAST - BY TYPE AND APPLICATIONS

15.1 Global Oligonucleotide Therapeutics Market Forecast by Types (2020-2025)
  15.1.1 Global Oligonucleotide Therapeutics Market Forecast Production and Market Share by Types (2020-2025)
  15.1.2 Global Oligonucleotide Therapeutics Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Oligonucleotide Therapeutics Market Forecast by Applications (2020-2025)

List Of Tables

LIST OF TABLES AND FIGURES

Figure Oligonucleotide Therapeutics Picture
Table Oligonucleotide Therapeutics Key Market Segments
Figure Study and Forecasting Years
Figure Global Oligonucleotide Therapeutics Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Oligonucleotide Therapeutics Value ($) and Growth Rate (2015-2020)
Table Global Oligonucleotide Therapeutics Value ($) by Countries (2015-2020)
Table Global Oligonucleotide Therapeutics Value Market Share by Regions (2015-2020)
Figure Global Oligonucleotide Therapeutics Value Market Share by Regions in 2019
Figure Global Oligonucleotide Therapeutics Production and Growth Rate (2015-2020)
Table Global Oligonucleotide Therapeutics Production by Major Countries (2015-2020)
Table Global Oligonucleotide Therapeutics Production Market Share by Major Countries (2015-2020)
Figure Global Oligonucleotide Therapeutics Production Market Share by Regions in 2019
Figure Global Oligonucleotide Therapeutics Consumption and Growth Rate (2015-2020)
Table Global Oligonucleotide Therapeutics Consumption by Regions (2015-2020)
Table Global Oligonucleotide Therapeutics Consumption Market Share by Regions (2015-2020)
Figure Global Oligonucleotide Therapeutics Consumption Market Share by Regions in 2019
Table Global Oligonucleotide Therapeutics Export Top 3 Country 2019
Table Global Oligonucleotide Therapeutics Import Top 3 Country 2019
Table United States Oligonucleotide Therapeutics Export and Import (2015-2020)
Table Europe Oligonucleotide Therapeutics Export and Import (2015-2020)
Table China Oligonucleotide Therapeutics Export and Import (2015-2020)
Table Japan Oligonucleotide Therapeutics Export and Import (2015-2020)
Table India Oligonucleotide Therapeutics Export and Import (2015-2020)
Table Global Oligonucleotide Therapeutics Production by Types (2015-2020)
Table Global Oligonucleotide Therapeutics Production Market Share by Types (2015-2020)
Figure Global Oligonucleotide Therapeutics Production Share by Type (2015-2020)
Table Global Oligonucleotide Therapeutics Value by Types (2015-2020)
Table Global Oligonucleotide Therapeutics Value Market Share by Types (2015-2020)
Figure Global Oligonucleotide Therapeutics Value Share by Type (2015-2020)
Figure Global Antisense Production and Growth Rate (2015-2020)
Figure Global Antisense Price (2015-2020)
Figure Global Ribozymes Production and Growth Rate (2015-2020)
Figure Global Ribozymes Price (2015-2020)
Figure Global Aptamers Production and Growth Rate (2015-2020)
Figure Global Aptamers Price (2015-2020)
Figure Global miRNA Production and Growth Rate (2015-2020)
Figure Global miRNA Price (2015-2020)
Figure Global CpG/Immunostimulatory Production and Growth Rate (2015-2020)
Figure Global CpG/Immunostimulatory Price (2015-2020)
Figure Global RNAi Production and Growth Rate (2015-2020)
Figure Global RNAi Price (2015-2020)
Figure Global Others Production and Growth Rate (2015-2020)
Figure Global Others Price (2015-2020)
Table Global Oligonucleotide Therapeutics Consumption by Applications (2015-2020)
Table Global Oligonucleotide Therapeutics Consumption Market Share by Applications (2015-2020)
Figure Global Oligonucleotide Therapeutics Consumption Share by Application (2015-2020)
Figure Global Infectious Diseases Consumption and Growth Rate (2015-2020)
Figure Global Oncology Consumption and Growth Rate (2015-2020)
Figure Global Neurodegenerative Disorders Consumption and Growth Rate (2015-2020)
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2015-2020)
Figure Global Kidney Diseases Consumption and Growth Rate (2015-2020)
Figure Global Others Consumption and Growth Rate (2015-2020)
Figure North America Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Table North America Oligonucleotide Therapeutics Consumption by Countries (2015-2020)
Table North America Oligonucleotide Therapeutics Consumption Market Share by Countries (2015-2020)
Figure North America Oligonucleotide Therapeutics Consumption Market Share by Countries (2015-2020)
Figure United States Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Canada Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Mexico Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Table Europe Oligonucleotide Therapeutics Consumption by Countries (2015-2020)
Table Europe Oligonucleotide Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Europe Oligonucleotide Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Germany Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure France Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Italy Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Spain Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Oligonucleotide Therapeutics Consumption by Countries (2015-2020)
Table Asia-Pacific Oligonucleotide Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Oligonucleotide Therapeutics Consumption Market Share by Countries (2015-2020)
Figure China Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Japan Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure South Korea Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure India Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Oligonucleotide Therapeutics Consumption by Countries (2015-2020)
Table Middle East and Africa Oligonucleotide Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Oligonucleotide Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure UAE Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure South Africa Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Figure South America Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Table South America Oligonucleotide Therapeutics Consumption by Countries (2015-2020)
Table South America Oligonucleotide Therapeutics Consumption Market Share by Countries (2015-2020)
Figure South America Oligonucleotide Therapeutics Consumption Market Share by Countries (2015-2020)
Figure Brazil Oligonucleotide Therapeutics Market Consumption and Growth Rate (2015-2020)
Table Gilead Company Profile
Table Gilead Production, Value, Price, Gross Margin 2015-2020
Figure Gilead Production and Growth Rate
Figure Gilead Value ($) Market Share 2015-2020
Table Santaris Pharma Company Profile
Table Santaris Pharma Production, Value, Price, Gross Margin 2015-2020
Figure Santaris Pharma Production and Growth Rate
Figure Santaris Pharma Value ($) Market Share 2015-2020
Table Ionis Pharmaceuticals Company Profile
Table Ionis Pharmaceuticals Production, Value, Price, Gross Margin 2015-2020
Figure Ionis Pharmaceuticals Production and Growth Rate
Figure Ionis Pharmaceuticals Value ($) Market Share 2015-2020
Table Regulus Therapeutics Company Profile
Table Regulus Therapeutics Production, Value, Price, Gross Margin 2015-2020
Figure Regulus Therapeutics Production and Growth Rate
Figure Regulus Therapeutics Value ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer Production and Growth Rate
Figure Pfizer Value ($) Market Share 2015-2020
Table ContraVir Company Profile
Table ContraVir Production, Value, Price, Gross Margin 2015-2020
Figure ContraVir Production and Growth Rate
Figure ContraVir Value ($) Market Share 2015-2020
Table PCI Biotech Company Profile
Table PCI Biotech Production, Value, Price, Gross Margin 2015-2020
Figure PCI Biotech Production and Growth Rate
Figure PCI Biotech Value ($) Market Share 2015-2020
Table Biogen Company Profile
Table Biogen Production, Value, Price, Gross Margin 2015-2020
Figure Biogen Production and Growth Rate
Figure Biogen Value ($) Market Share 2015-2020
Table Alnylam Company Profile
Table Alnylam Production, Value, Price, Gross Margin 2015-2020
Figure Alnylam Production and Growth Rate
Figure Alnylam Value ($) Market Share 2015-2020
Table Merck Company Profile
Table Merck Production, Value, Price, Gross Margin 2015-2020
Figure Merck Production and Growth Rate
Figure Merck Value ($) Market Share 2015-2020
Table SomaGenics Company Profile
Table SomaGenics Production, Value, Price, Gross Margin 2015-2020
Figure SomaGenics Production and Growth Rate
Figure SomaGenics Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Oligonucleotide Therapeutics Market Forecast Production by Types (2020-2025)
Table Global Oligonucleotide Therapeutics Market Forecast Production Share by Types (2020-2025)
Table Global Oligonucleotide Therapeutics Market Forecast Value ($) by Types (2020-2025)
Table Global Oligonucleotide Therapeutics Market Forecast Value Share by Types (2020-2025)
Table Global Oligonucleotide Therapeutics Market Forecast Consumption by Applications (2020-2025)
Table Global Oligonucleotide Therapeutics Market Forecast Consumption Share by Applications (2020-2025)